 |
|
Hormone Replacement Therapy and Peripheral Arterial Disease
The Rotterdam Study
Iris C. D. Westendorp, MD, PhD;
Bas A. in't Veld, MD, MSc;
Diederik E. Grobbee, MD, PhD;
Huib A. P. Pols, MD, PhD;
Wonter T. Meijer, MD, PhD;
Albert Hofman, MD, PhD;
Jacqueline C. M. Witteman, MD, PhD
Arch Intern Med. 2000;160:2498-2502.
Background As the number of elderly women increases in Western society, peripheral arterial disease (PAD) is likely to become an increasing problem. Hormone replacement therapy, suggested to protect against coronary atherosclerosis, might also inhibit the development of PAD.
Methods The association between hormone replacement therapy and the presence of PAD was studied in a population-based study consisting of 2196 naturally menopausal women aged 55 to 80 years living in a suburban area of Rotterdam, the Netherlands. Peripheral arterial disease was defined as an ankle/arm systolic blood pressure index (ratio of the systolic blood pressure at the ankle to the systolic blood pressure at the arm) lower than 0.9.
Results Hormone replacement therapy for 1 year or longer was associated with a 52% decreased risk of PAD (odds ratio, 0.48 [95% confidence interval, 0.24-0.85]), while no association was found for therapy duration shorter than 1 year (odds ratio, 0.97 [95% confidence interval, 0.58-1.63) after adjustment for age, smoking, and socioeconomic status. Additional adjustment for body mass index, age at menopause, total cholesterol and high-density lipoprotein cholesterol, alcohol intake, and frequency of visits to health care facilities did not change the results.
Conclusion The findings of this population-based study suggest that hormone replacement therapy given for a year or more is associated with a decreased risk of PAD among postmenopausal women.
From the Departments of Epidemiology and Biostatistics (Drs Westendorp, in't Veld, Grobbee, Pols, Meijer, Hofman, and Witteman), Internal Medicine III (Dr Pols), and General Practice (Dr Meijer), Erasmus University Medical School, Rotterdam, and the Julius Center for Patient Oriented Research, University Medical Center Utrecht, Utrecht (Dr Grobbee), the Netherlands.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hormone Replacement Therapy and Peripheral Vascular Disease in Women
Nguyen et al.
VASC ENDOVASCULAR SURG 2004;38:547-556.
ABSTRACT
Reproductive History in Women with Lower Limb Ischemia
Hultgren et al.
ANGIOLOGY 2004;55:373-383.
ABSTRACT
The effect of 17{beta}-estradiol on MCP-1 serum levels in postmenopausal women
Stork et al.
Cardiovasc Res 2002;53:642-649.
ABSTRACT
| FULL TEXT
Medical Treatment of Peripheral Arterial Disease and Claudication
Hiatt
NEJM 2001;344:1608-1621.
FULL TEXT
|
